tiprankstipranks
Trending News
More News >
ImmunoCellular Therapeutics (IMUC)
OTHER OTC:IMUC
US Market

Compare ImmunoCellular Therapeutics (IMUC) vs. Competitors

Compare
186 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
ImmunoCellular Therapeutics
$0.12
$13.59M
-11.95%
Xenetic Biosciences
$2.21
$4.99M
-1.02
-49.94%
Adial Pharmaceuticals
$0.22
$4.36M
-0.15
-83.25%
1 Buy
0 Hold
0 Sell
Moderate Buy
VYNE Therapeutics
$0.58
$19.22M
-0.70
-76.93%
1 Buy
1 Hold
0 Sell
Moderate Buy
IN8bio
$1.96
$19.14M
-0.29
-77.92%
3 Buy
0 Hold
0 Sell
Strong Buy
Bolt Biotherapeutics
$5.48
$10.52M
-0.24
-45.01%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMUC
ImmunoCellular Therapeutics
0.14
0.01
7.69%
XBIO
Xenetic Biosciences
2.08
-2.01
-49.14%
ADIL
Adial Pharmaceuticals
0.14
-0.65
-82.66%
VYNE
VYNE Therapeutics
0.56
-1.86
-77.02%
INAB
IN8bio
1.90
-6.41
-77.14%
BOLT
Bolt Biotherapeutics
5.40
-4.60
-46.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts